Life Sciences Disruption Series

Disruption and innovation go hand in hand in the life sciences industry. In our Life Sciences Disruption Series, our lawyers discuss key trends and how our teams collaborate to solve problems for clients. Our team’s 360-degree approach helps pharmaceutical, medical device and other stakeholders navigate the complex regulatory and compliance landscape to ensure that our clients can continue to offer breakthrough treatments, diagnostics and services to improve patient health.

LEARN MORE

Life Sciences and Healthcare

Back to Life Sciences Disruption Series

Disruption and innovation go hand in hand in the life sciences industry. In our Life Sciences Disruption Series, our lawyers discuss key trends and how our teams collaborate to solve problems for clients. Our team’s 360-degree approach helps pharmaceutical, medical device and other stakeholders navigate the complex regulatory and compliance landscape to ensure that our clients can continue to offer breakthrough treatments, diagnostics and services to improve patient health.

LEARN MORE

Life Sciences and Healthcare

New Pathways, New Opportunities in Digital Health and Biologics

Lisa Dwyer and Eva Temkin, who are both former FDA officials, discuss trends in the digital health and biologics space and ways to navigate those challenges with the FDA.

Watch Now

Drug Pricing: What’s at Stake

Liz Lindquist and John Shakow explore critical issues for pharmaceutical companies on drug pricing.

Watch Now

The COVID Pandemic’s Impact on Litigation

Kristen Fournier and Mandi Klingler discuss emerging litigation trends arising from the pandemic and how we help clients proactively prepare for them.

Watch Now

The Approach to Compliance and Investigations for Life Sciences Companies

Mark Jensen and Nikki Reeves share how resolving compliance challenges can help mitigate risk of litigation.

Watch Now